X0306 4 2021-03-08 0001682852 Moderna, Inc. MRNA 0001690927 Zaks Tal Zvi C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Medical Officer Common Stock 2021-03-08 4 M 0 10000 20.93 A 10000 D Common Stock 2021-03-08 4 M 0 1478 12.21 A 11478 D Common Stock 2021-03-08 4 M 0 5000 14.22 A 16478 D Common Stock 2021-03-08 4 S 0 1547 123.48 D 14931 D Common Stock 2021-03-08 4 S 0 273 124.35 D 14658 D Common Stock 2021-03-08 4 S 0 1361 125.68 D 13297 D Common Stock 2021-03-08 4 S 0 1350 126.75 D 11947 D Common Stock 2021-03-08 4 S 0 1855 127.73 D 10092 D Common Stock 2021-03-08 4 S 0 2698 128.62 D 7394 D Common Stock 2021-03-08 4 S 0 2312 129.80 D 5082 D Common Stock 2021-03-08 2021-03-08 4 S 0 2611 130.76 D 2471 D Common Stock 2021-03-08 4 S 0 2000 131.83 D 471 D Common Stock 2021-03-08 4 S 0 471 132.91 D 0 D Stock Option (Right to Buy) 20.93 2021-03-08 4 M 0 10000 0 D 2029-03-08 Common Stock 10000 180798 D Stock Option (Right to Buy) 12.21 2021-03-08 4 M 0 1478 0 D 2027-02-23 Common Stock 1478 0 D Stock Option (Right to Buy) 14.22 2021-03-08 4 M 0 5000 0 D 2028-02-28 Common Stock 5000 40175 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.88 to $123.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $124.00 to $124.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $125.13 to $126.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.14 to $127.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.25 to $128.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.26 to $129.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $129.31 to $130.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.33 to $131.29. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.44 to $132.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.46 to $133.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter. /s/ Brian Sandstrom, as Attorney-in-Fact 2021-03-10